RTW Biotech Opportunities (LSE:RTW) ROE % Adjusted to Book Value: 97.35% (As of Dec. 2025)


LSE:RTW RTW Biotech Opportunities Ltd LSE:RTW
36 GF Score
Price $2.40
! 2 Warning Signs
View Full Analysis

What is RTW Biotech Opportunities ROE % Adjusted to Book Value?

RTW Biotech Opportunities LSE:RTW +3.00% 36 ROE % Adjusted to Book Value is 97.35% as of Dec. 2025. GuruFocus rates LSE:RTW with a GF Score™ of 36/100. The stock has 2 warning signs investors should review.

RTW Biotech Opportunities's ROE % for the quarter that ended in Dec. 2025 was 78.85%. RTW Biotech Opportunities's PB Ratio for the quarter that ended in Dec. 2025 was 0.81. RTW Biotech Opportunities's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 was 97.35%.

RTW Biotech Opportunities ROE % Adjusted to Book Value Related Terms

RTW Biotech Opportunities ROE % Adjusted to Book Value Historical Data

* Premium members only.

The historical data trend for RTW Biotech Opportunities's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RTW Biotech Opportunities ROE % Adjusted to Book Value Chart

RTW Biotech Opportunities Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
ROE % Adjusted to Book Value
Get a 7-Day Free Trial -16.42 -14.50 31.04 8.70 40.42

RTW Biotech Opportunities Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 36.30 0.00 -22.07 -19.68 97.35

LSE:RTW vs BLK, BX, KKR: ROE % Adjusted to Book Value Comparison

For the Asset Management subindustry, RTW Biotech Opportunities's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RTW Biotech Opportunities ROE % Adjusted to Book Value vs Asset Management Industry

For the Asset Management industry and Financial Services sector, RTW Biotech Opportunities's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where RTW Biotech Opportunities's ROE % Adjusted to Book Value falls into.


LSE:RTW
36GF Score
RTW Biotech Opportunities Ltd LSE:RTW
ROE % Adjusted to Book Value is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RTW Biotech Opportunities ROE % Adjusted to Book Value Calculation

RTW Biotech Opportunities's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=32.74% / 0.81
=40.42%

RTW Biotech Opportunities's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2025 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=78.85% / 0.81
=97.35%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a ROE % Adjusted to Book Value of 97.35% mean?
RTW Biotech Opportunities (LSE:RTW) has a ROE % Adjusted to Book Value of 97.35% as of Dec. 2025. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on RTW Biotech Opportunities and its competitors.
Is RTW Biotech Opportunities' ROE % Adjusted to Book Value too high?
RTW Biotech Opportunities' current ROE % Adjusted to Book Value is 97.35%. Overall, RTW Biotech Opportunities has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does RTW Biotech Opportunities' ROE % Adjusted to Book Value compare to BLK and BX?
RTW Biotech Opportunities' ROE % Adjusted to Book Value of 97.35% can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for an Asset Management company?
A good ROE % Adjusted to Book Value depends on the Asset Management industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on RTW Biotech Opportunities and its competitors. RTW Biotech Opportunities's current ROE % Adjusted to Book Value is 97.35%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RTW Biotech Opportunities stock overvalued right now?
RTW Biotech Opportunities (LSE:RTW) has a current ROE % Adjusted to Book Value of 97.35%. The current ROE % Adjusted to Book Value is 97.35%. RTW Biotech Opportunities' overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For RTW Biotech Opportunities (LSE:RTW), the current ROE % Adjusted to Book Value is 97.35% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RTW Biotech Opportunities Business Description

Address St Julian’s Avenue, 1st Floor, Royal Chambers, St Peter Port, GGY, GY1 3JX
RTW Biotech Opportunities Ltd is a life sciences and investment fund focused on identifying transformative assets with high growth potential across the biopharma and medtech sectors. It is powering medical breakthroughs that have the potential to transform the wellbeing of people around the world. Its portfolio includes Neurology, Oncology, Inflammation, Cardiovascular, Metabolic, Pulmonary, Ophthalmology, Rare Disease, and Other. Geographically it operates in USA & Canada, the Rest of World, and UK & EU, with the majority of the revenue deriving from USA & Canada.
36GF Score

Get the complete analysis for LSE:RTW

ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.40
Price